Trexquant Investment’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-2,644
Closed -$353K 1451
2018
Q4
$353K Buy
+2,644
New +$433K 0.02% 735
2018
Q3
Sell
-16,525
Closed -$2.75M 1307
2018
Q2
$2.75M Buy
+16,525
New +$2.65M 0.19% 177
2015
Q2
Sell
-3,300
Closed -$982K 1345
2015
Q1
$982K Buy
+3,300
New +$941K 0.1% 374

Other funds holding AGN

Trexquant Investment's AGN Position: Q1 2019 in Review

Trexquant Investment sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 2,644 shares — an estimated $353K sold.

Trexquant Investment first reported a position in AGN in Q1 2015 and held it in 3 quarters. The position peaked at $2.75M in Q2 2018. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Trexquant Investment reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Trexquant Investment sold 2,644 Allergan plc shares in Q1 2019, an estimated $353K.
  • Trexquant Investment first reported a position in Allergan plc in Q1 2015 and held it in 3 quarters.
  • Trexquant Investment's Allergan plc position peaked at $2.75M in Q2 2018.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Trexquant Investment's 13F filing for Q1 2019, filed 13 May 2019.